ask="N/A"
ask_size="N/A"
average_daily_volume="73575"
bid="8.50"
bid_size="1900"
book_value="3.83"
change="+0.05"
change_from_200_day_moving_average="-1.30"
change_from_50_day_moving_average="-0.42"
change_from_52_week_high="-6.51"
change_From_52_week_low="1.10"
change_in_percent="+0.54%"
close="9.37"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.85"
ebitda="-19.31M"
eps_estimate_current_year="-1.80"
eps_estimate_next_quarter="-0.46"
eps_estimate_next_year="-1.71"
ex_dividend_date="N/A"
float_shares="7487000"
high="9.74"
high_52_weeks="15.88"
last_trade_date="3/1/2017"
last_trade_price="9.37"
last_trade_size="942"
last_trade_time="4:00pm"
low="8.93"
low_52_weeks="8.27"
market_capitalization="157.16M"
moving_average_200_day="10.67"
moving_average_50_day="9.79"
name="Obalon Therapeutics
Inc."
notes="N/A"
one_year_target_price="19.75"
open="9.40"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-12.18%"
percent_change_from_50_day_moving_average="-4.27%"
percent_change_from_52_week_high="-40.99%"
percent_change_from_52_week_low="+13.30%"
previous_close="9.32"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.43"
price_per_sales="46.07"
revenue="3.39M"
shares_outstanding="16773000"
short_ratio="6.84"
stock_exchange="NGM"
symbol="OBLN"
volume="94713"
weeks_range_52="8.27 - 15.88"
